Wednesday, 07 November 2018, 1:17 PM PT (04:17 pm ET)
On Wednesday, Apple has released its second developer pad for iOS 12.1.1 and tvOS 12.1.1 for testing and has launched the beta cycle for Apple Watch again with the first developer script for watchOS 5.1.2.
IOS 12.1 Developer Software Software Update screen
Developers registered in the test program can access the latest buildings after they have completed an upgraded update on their registered devices or can follow the Apple Developer Center guidelines. Public beta versions usually arrive within a few days of the developer beta and can be purchased from the Apple beta software website.
Another iOS 12.1.1 developer beta is Chapter 16C5043b, replacing the first beta structure 16C5036c.
IOS update seems to have a more incremental structure, but relatively few modifications have been found to date in the operating system, but the addition of naming seems to include debugging and performance enhancements.
FaceTime appears to be the most important beneficiary of the update, which can take a live photo during a call, and changes to the lowest bar include, among other things, naming button features and camera replacement.
The first beta to watchOS 5.1.2 has been built with 16S5042a. Apple unexpectedly introduced watchOS 5.1.1 without any bets on Monday.
The upgrade is generally expected to contain new complications Infograph and Infograph Modular Face, adding elements to Messages, Home and Mail.
The second beta of TVOS is built with 16K5041a, replacing the first beta structure 16K5035b. There are few details about the latest features of the tvOS Bea and are likely to be bug fixes, performance and compatibility with iOS 12.1.1.
AppleInsider, and Apple itself is telling beta users that they will not be able to install software on "critical devices," such as primary devices, because of potential losing information due to other potential issues. It is advisable to use secondary or non-essential hardware for beta testing and that regular backups of important data are performed.